Sarcopenia is a bad harbinger of cancer-related survival in rectal cancer

Sema Yilmaz Rakici, Rahmi Atil Aksoy, Gulen Burakgazi, Ozlem Terzi, Esra Aydin, Zihni Acar Yazici, Nilgun Ozbek Okumus · 2025

Read Sarcopenia is a bad harbinger of cancer-related survival in rectal cancer by Sema Yilmaz Rakici, Rahmi Atil Aksoy, Gulen Burakgazi, Ozlem Terzi, Esra Aydin, Zihni Acar Yazici, Nilgun Ozbek Okumus (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12720608.txt.

Description

Sema Yilmaz Rakici and six co-authors link muscle wasting to worse survival in rectal cancer, in a two thousand twenty-five oncology paper. Sarcopenia was assessed jointly from imaging and blood markers rather than either alone.

Patients who died were older and had smaller pre-treatment muscle, subcutaneous fat, and visceral fat volumes than survivors. Larger volumes above derived cutoffs meant longer survival. Low albumin and high Fib-4 fibrosis scores also predicted death, and post-treatment albumin was the lone independent prognostic factor in multivariate analysis. Complete responders carried notably higher albumin. The authors propose the combined profile as a sarcopenia warning system during neoadjuvant therapy.

Catalog record

CREATORSema Yilmaz Rakici, Rahmi Atil Aksoy, Gulen Burakgazi, Ozlem Terzi, Esra Aydin, Zihni Acar Yazici, Nilgun Ozbek Okumus
YEAR2025
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC12720608

Browse the full library · About the Tower of Babel